Company intelligence / Profile preview

CH Biotech

Nantou City, Taiwanexpo.bioasiataiwan.com ↗

Ownership: Private
Development stage: Commercial

Overview

CH Biotech develops and commercializes innovative plant growth regulators, plant growth promoters, and fertilizers to enhance crop yield and quality. The company leverages advanced research in plant gene expression regulation for sustainable agriculture. It has achieved strong profitability since its early years. Clinical results do not apply as it does not develop human therapeutics.

Therapeutic areas: Other
Modalities: Small molecule
Industry: Agriculture & AgTech

Drug pipeline

1 asset

Radiate

Commercial

Indications: Agricultural crop enhancement, Plant stress resistance

Beyond the preview

Go deeper on CH Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CH Biotech.

Explore the full profile